AGN-195263 / AbbVie - LARVOL DELTA

Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye (clinicaltrials.gov) - P3; N=527; Terminated; Sponsor: Allergan; Recruiting ➔ Terminated; Trial primary completion date: Oct 2019 ➔ Jun 2017

Trial primary completion date • Trial termination • Biosimilar • Dry Eye Disease

Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye (clinicaltrials.gov) - P3; N=36; Terminated; Sponsor: Allergan; N=18 ➔ 36

Enrollment change